Tempest Therapeutics Q1 2026 Earnings WiderthanExpected Loss Amid PreRevenue Development Stage CLST Q3 2025 Earnings Modest Profitability with Stable Operations CDNL Q1 2026 Earnings EPS Surges 2885 Above Estimates AQN Q1 2026 Earnings EPS Surges Past Estimates Amid Utility Segment Strength PLBY Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Rallies Despite Weakness AN2 Therapeutics ANTX Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline CapsoVision Inc CV Q1 2026 Earnings WiderThanExpected Loss Weighs on Results but Shares Edge Higher